Dietary advanced lipoxidation products as risk factors for human health - A call for data

Molecular Nutrition and Food Research

Volumn 51, Issue 9, 2007, Pages 1091-1093

  Monnier, Vincent M ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Food; Glycation; Lipids; Maillard reaction; Oxidation

Indexed keywords

ANIMAL; DIET; FOOD; HUMAN; INFLAMMATION; LIPID PEROXIDATION; REVIEW; RISK FACTOR;

ANIMALS; DIET; FOOD; HUMANS; INFLAMMATION; LIPID PEROXIDATION; RISK FACTORS;

EID: 34948887197     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700030     Document Type: Review

References (14)

1. Bolton, W. K., Cattran, D. C., Williams, M. E., Adler, S. G., et al., Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy, Am. J. Nephrol. 2004, 24, 32-40.
2. Viberti, G., Slama, G., Pozza, G., Czyzyk, A., et al., Early closure of European Pimagedine trial. Steering Committee. Safety Committee, Lancet 1997, 350, 214-215.
3. Fu, M. X., Requena, J. R., Jenkins, A. J., Lyons, T. J., et al., The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidationreactions, J. Biol. Chem. 1996, 271, 9982-9986.
4. Mason, J. B., Nutritional chemoprevention of colon cancer, Semin. Gastrointest. Dis. 2002, 13, 143-153.
5. Vlassara, H., Cai, W., Crandall, J., Goldberg, T., et al., Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy, Proc. Natl. Acad. Sci. USA 2002, 99, 15596-15601.
6. Herder, C., Peltonen, M., Koenig, W., Kraft, I., et al., Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: Results from the Finnish Diabetes Prevention Study, Diabetes 2006, 55, 2340-2346.
7. Salas-Salvado, J., Bullo, M., Garcia-Lorda, P., Figueredo, R., et al., Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss, Int. J. Obes. (Land.) 2006, 30, 1714-1720.
8. Van Guilder, G. P., Hoetzer, G. L., Greiner, J. J., Stauffer, B. L., Desouza, C. A., Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults, Obesity (Silver Spring) 2006, 14, 2127-2131.
9. Turnbull, C., Hodgson, S., Genetic predisposition to cancer, Clin. Med. 2005, 5, 491-498.
10. Taguchi, A., Blood, D. C., del Toro, G., Canet, A., et al., Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases [see comments], Nature 2000, 405, 354-360.
11. Hung, H. C., Joshipura, K. J., Jiang, R., Hu, F. B., et al., Fruit and vegetable intake and risk of major chronic disease, J. Natl. Cancer Inst. 2004, 96, 1577-1584.
12. Ames, B. N., Identifying environmental chemicals causing mutations and cancer, Science 1979, 204, 587-593.
13. Forster, A., Kuhne, Y., Henle, T., Studies on absorption and elimination of dietary maillard reaction products, Ann. NY Acad. Sci. 2005, 1043, 474-481.
14. Erbersdobler, H. F., Faist, V., Maillard reaction products: Uptake, metabolic transit and selected parameters of biopotency and safety, Forum Nutr. 2003, 56, 353-355.